| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | Venrock Healthcare Capital Partners III, L.P. | 5.30M | $84.63M | - |
| CEO | 424.5K | $6.77M | - | |
| CEO | Palleiko Benjamin L | 416.2K | $6.64M | - |
| Other | 223.5K | $3.57M | - | |
| Other | Yea Christopher | 221.0K | $3.53M | - |
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2020-10-16 | Feener Edward P. | Chief Scientific Officer | Sell | 993 | $17.00 | $16,881.00 | -1.0% | → |
| 2020-10-16 | Crockett Thomas Andrew | CEO | Sell | 1,261 | $17.01 | $21,444.06 | -0.5% | → |
| 2020-02-05 | Yea Christopher | Chief Development Officer | Sell | 100 | $17.10 | $1,710.00 | -0.1% | → |
| 2020-02-05 | Feener Edward P. | Chief Scientific Officer | Sell | 100 | $17.11 | $1,711.00 | -0.1% | → |
| 2020-02-05 | Crockett Thomas Andrew | CEO | Sell | 200 | $17.05 | $3,410.00 | - | → |
| 2019-12-20 | Yea Christopher | Chief Development Officer | Sale+OE | 2,646 | $17.02 | $45,025.13 | -3.1% | → |
| 2019-12-20 | Crockett Thomas Andrew | CEO | Sell | 2,300 | $17.02 | $39,150.37 | -1.0% | → |
| 2019-12-16 | Yea Christopher | Chief Development Officer | Sale+OE | 4,709 | $17.05 | $80,269.34 | -1.9% | → |
| 2019-12-16 | Crockett Thomas Andrew | CEO | Sell | 7,700 | $17.06 | $131,352.30 | -1.0% | → |
| 2019-09-27 | SOLAND DANIEL B | - | Buy | 10,000 | $11.87 | $118,749.99 | +490.7% | → |
| 2019-07-29 | Cha Albert | - | Buy | 56,367 | $16.99 | $957,737.10 | +2.6% | → |
| 2019-07-23 | Feener Edward P. | Chief Scientific Officer | Sell | 3,300 | $18.62 | $61,443.01 | -1.7% | → |
| 2019-07-22 | Yea Christopher | Chief Development Officer | Sale+OE | 7,355 | $18.35 | $134,929.68 | -8.1% | → |
| 2019-07-19 | Cha Albert | - | Buy | 61,280 | $17.79 | $1,090,295.69 | +3.0% | → |
| 2019-07-15 | Crockett Thomas Andrew | CEO | Sell | 10,000 | $17.04 | $170,407.00 | -3.9% | → |
| 2019-04-22 | Yea Christopher | Chief Development Officer | Sale+OE | 7,355 | $26.04 | $191,529.84 | -4.2% | → |
| 2019-04-22 | Palleiko Benjamin L | CBO, CFO and Secretary | Sale+OE | 3,073 | $25.70 | $78,976.41 | -4.5% | → |
| 2019-04-17 | Feener Edward P. | Chief Scientific Officer | Sell | 4,000 | $24.92 | $99,666.27 | -2.0% | → |
| 2019-04-15 | Crockett Thomas Andrew | CEO | Sell | 10,000 | $24.80 | $247,957.72 | -1.9% | → |
| 2019-04-10 | SVLSF IV, LLC | 10% Owner | Sell | 50,000 | $29.20 | $1,460,145.18 | -1.0% | → |
| 2019-04-05 | Maetzel Andreas | Senior Vice President Medical | Sale+OE | 5,000 | $30.00 | $150,011.00 | -100% | → |
| 2019-04-02 | SVLSF IV, LLC | 10% Owner | Sell | 97,074 | $28.03 | $2,720,896.65 | -1.8% | → |
| 2019-03-28 | SVLSF IV, LLC | 10% Owner | Sell | 36,665 | $27.80 | $1,019,323.66 | -1.9% | → |